Novavax | NVAX - 流動負債





流動負債 変化する 日付
Adma Biologics USD 69.54M 13.05M 2025-12
Agenus USD 323.49M 36.36M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Cassava Sciences USD 43.83M 4.21M 2025-12
Geron USD 113.82M 26.11M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
MannKind USD 171.03M 61.9M 2025-12
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.29M 381K 2025-12
Moderna USD 1.99B 306M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 459.95M 30.08M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12